Home / Recalls / Viatris, Inc. / D-0444-2026

D-0444-2026 Class II Ongoing

Recalled by Viatris, Inc. — Canonsburg, PA

Recall Details

Product Type
Drugs
Report Date
April 15, 2026
Initiation Date
March 17, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

US Nationwide.

Code Information

Lot# 8177156, Exp Date: 02/28/2027

Other recalls by Viatris, Inc.

  • D-0204-2025 Class II — Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, (December 23, 2024)
  • D-0203-2025 Class II — Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, (December 23, 2024)
  • D-0123-2025 Class II — Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0119-2025 Class II — Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0124-2025 Class II — Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0122-2025 Class II — Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0128-2025 Class II — Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0126-2025 Class II — Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0120-2025 Class II — Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0121-2025 Class II — Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)